The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU

• Conditions: Mortality; Phosphate Deficiency; Covid19

• Registration Number: NCT04800770
• Lead Sponsor: Ankara City Hospital Bilkent

Brief Summary

The investigators aimed to investigate the relationship between phosphate level and mortality using the 4C Mortality Score in COVID-19 patients who were followed up in the intensive care unit.

Detailed Description

Not available

Study Timeline

• Status Verified: 2021-03
• Study Start: 2021-03-03
• Study First Submitted: 2021-03-10
• Study First Submitted QC: 2021-03-15
• Last Update Submitted: 2021-03-15
• Study First Posted: 2021-03-16
• Last Update Posted: 2021-03-16
• Primary Completion: 2021-06-15
• Study Completion: 2021-07-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

• Participants hospitalized in the intensive care unit diagnosed with COVID-19 will incluse in the study

Exclusion Criteria

• there is no exclusion criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mortality	28 days	mortality percentage of patients in 28 days
4C mortality score	6 months	4C Mortality Scores of the patients will be calculated, according to age, gender, number of comorbidities, respiratory rate, SpO2, GCS, urea, and CRP parameters
serum phosphate levels	6 months	mg/dl

Trial Locations

Locations (1)

Ankara City Hospital; 🇹🇷 Ankara, Turkey